Related Experiment Video
Updated: Jun 3, 2026

05:28
Clinical Imaging of Microwave Mammography
Published on: November 14, 2025
Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors
Jagpreet Chhatwal1, Oguzhan Alagoz, Elizabeth S Burnside
1Health Economic Statistics, Merck Research Laboratories, North Wales, Pennsylvania 19454, jagpreet_chhatwal@merck.com.
Operations Research
|March 19, 2011
Summary
This study introduces a Markov decision process model to optimize breast biopsy decisions. The model suggests biopsy recommendations should consider patient age, improving accuracy over human radiologists.
Area of Science:
- Radiology
- Medical Decision Making
- Biostatistics
Background:
- Breast cancer is a leading cancer in US women, with millions of mammograms performed annually.
- Over 700,000 breast biopsies are conducted yearly in the US, but 55-85% reveal benign lesions, leading to overtreatment and costs.
- Current radiologist decision-making for biopsies lacks a standardized, data-driven approach considering patient demographics.
Purpose of the Study:
- To develop an optimal decision-making model for breast biopsy referrals based on mammographic findings and patient demographics.
- To address the problem of unnecessary biopsies and their associated patient anxiety and healthcare expenditures.
- To create a model that assists radiologists in making more accurate biopsy decisions.
Main Methods:
- Formulation of the breast biopsy decision problem as a finite-horizon discrete-time Markov decision process.
- Development of an optimal policy derived from the Markov decision process model.
- Application and validation of the model using clinical data to compare its performance against radiologists.
Main Results:
- The optimal policy indicates that patient age is a critical factor in biopsy decisions.
- The model recommends a higher risk threshold for biopsy in older patients compared to younger patients.
- The developed model demonstrated superior performance compared to human radiologists in clinical data analysis for biopsy decision-making.
Conclusions:
- A Markov decision process model provides an effective framework for optimizing breast biopsy decisions.
- Incorporating patient age into the decision-making process can significantly improve the accuracy of biopsy recommendations.
- The model offers a data-driven approach to reduce unnecessary biopsies, patient anxiety, and healthcare costs in breast cancer screening.

